Strong Tower Advisory Services’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-3,345
Closed -$312K 87
2023
Q3
$312K Buy
3,345
+109
+3% +$12.3K 0.16% 84
2023
Q2
$416K Buy
3,236
+76
+2% +$9.19K 0.2% 81
2023
Q1
$367K Sell
3,160
-132
-4% -$14.8K 0.19% 82
2022
Q4
$373K Buy
3,292
+76
+2% +$8.34K 0.22% 80
2022
Q3
$259K Hold
3,216
0.15% 91
2022
Q2
$240K Buy
3,216
+48
+2% +$4.38K 0.13% 101
2022
Q1
$405K Sell
3,168
-36
-1% -$3.94K 0.21% 88
2021
Q4
$430K Buy
3,204
+592
+23% +$85.1K 0.23% 89
2021
Q3
$358K Buy
+2,612
New +$329K 0.21% 85

Other funds holding DXCM

Strong Tower Advisory Services's DXCM Position: Q4 2023 in Review

Strong Tower Advisory Services sold out of DexCom (DXCM) in Q4 2023, closing a stake of 3,345 shares — an estimated $312K sold.

Strong Tower Advisory Services first reported a position in DXCM in Q3 2021 and held it in 9 quarters. The position peaked at $430K in Q4 2021. 974 funds tracked by Wall St. Rank hold DXCM as of Q4 2023.

  • Strong Tower Advisory Services reported no remaining DexCom position as of Q4 2023 after selling out during the quarter.
  • Strong Tower Advisory Services sold 3,345 DexCom shares in Q4 2023, an estimated $312K.
  • Strong Tower Advisory Services first reported a position in DexCom in Q3 2021 and held it in 9 quarters.
  • Strong Tower Advisory Services's DexCom position peaked at $430K in Q4 2021.
  • 974 funds tracked by Wall St. Rank held DexCom as of Q4 2023.

Based on Strong Tower Advisory Services's 13F filing for Q4 2023, filed 18 Jan 2024.